Switching sides—fingolimod versus injectable MS therapies
Crossref DOI link: https://doi.org/10.1038/nrneurol.2015.59
Published Online: 2015-04-21
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rossman, Ian T.
Cohen, Jeffrey A.
Text and Data Mining valid from 2015-04-21
Article History
First Online: 21 April 2015
Competing interests
: J.A.C. reports personal compensation for consulting from Genentech. I.T.R. declares no competing interests.